Archives of Clinical Gastroenterology
Research Article
The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients
http://www.peertechz.com/Clinical-Gastroenterology/pdf/ACG-1-104.pdf
Research Article
The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients
Aim: We evaluated food intake in telaprevir-based triple therapy
(telaprevir, pegylated-interferon, and ribavirin) and its relation to Gastric Emptying
(GE).
Methods: 17 patients received telaprevir
combined with pegylated interferon plus ribavirin. The GE study was carried out
using the 13C-acetate breath test
and GE time was expressed as the peak time of 13CO2 excretion (Tmax). Results: The average food intake was 1,851 ± 91, 1,338 ± 537 and 1,453 ± 537 kcal at 0, 1,
and 2 weeks after the start of treatment, respectively, showing a significant
decrease compared to that before treatment (p < 0.01 and p <0.05, paired
t-test). The averages of Tmax values at 0, 1, and 2 weeks after the start of
treatment were 48.4 ± 14.3 min, 56.9 ± 18.4 min and 58.0 ± 19.9 min, respectively. There was a significant difference between
baseline and 1 week after the start of treatment (p<0.05, paired t-test). Food
intake (kcal) showed a good correlation with the decrease of Tmax values
(minutes) (Pearson’s correlation test, r = -0.49, p < 0.05).
Conclusions: Telaprevir-based triple
therapy caused reduced food intake and worsened GE. http://www.peertechz.com/Clinical-Gastroenterology/pdf/ACG-1-104.pdf
Comments
Post a Comment